Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37−0.03 (-7.82%)
Close on Nov 17, 2026Market cap $1.29MP/E –Yield –
Scinai Immunotherapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Scinai Immunotherapeutics's total debt was $382.00K at Dec 31, 2022. For fiscal 2022 it was $382.00K, up 1.9% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $382.00K | +1.9% |
| FY2021 | Dec 31, 2021 | $375.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $382.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $375.00K | – |
See a number that looks wrong?